Neuropsychology for movement disorders neurosurgery

被引：3
作者：
Saint-Cyr, JA
机构：
[1] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada
[2] Univ Toronto, Univ Hlth Network, Dept Surg Neurosurg, Toronto, ON, Canada
[3] Univ Toronto, Univ Hlth Network, Dept Psychol, Toronto, ON, Canada
[4] Toronto Western Hosp, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 2003年 / 30卷
关键词：
D O I：
10.1017/S0317167100003280
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The neuropsychologist plays a crucial role in three phases of the neurosurgical treatment of movement disorder patients, namely screening, outcome evaluation and research. In screening patients, the differential diagnosis of dementia, impact of depression or other psychiatric conditions, and the influence of disease and medication-induced symptoms on cognitive performance must be determined. Postoperatively, systematic evaluations elucidate the cognitive costs or benefits of the procedure. The neuropsychologist is then able to provide feedback and counselling to the professional staff, patient and family to inform management strategies. Neuropsychologists also study alteration of cognitive processing due to lesions or stimulation, which, in tandem with functional imaging, shed light on plasticity in cortical and subcortical processing.
引用
收藏
页码：S83 / S93
页数：11
相关论文
共 193 条
[1]   Frequency of dementia in Parkinson disease [J].
Aarsland, D ;
Tandberg, E ;
Larsen, JP ;
Cummings, JL .
ARCHIVES OF NEUROLOGY, 1996, 53 (06) :538-542
[2]   Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease [J].
Aarsland, D ;
Ballard, C ;
McKeith, I ;
Perry, RH ;
Larsen, JP .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 13 (03) :374-379
[3]  
ABSHER JR, 1993, HDB NEUROPSYCHOLOGY, P315
[4]   FELINE SUBTHALAMIC NUCLEUS NEURONS CONTAIN GLUTAMATE-LIKE BUT NOT GABA-LIKE OR GLYCINE-LIKE IMMUNOREACTIVITY [J].
ALBIN, RL ;
ALDRIDGE, JW ;
YOUNG, AB ;
GILMAN, S .
BRAIN RESEARCH, 1989, 491 (01) :185-188
[5]  
ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119
[6]  
[Anonymous], 1992, NEUROPSYCHOLOGICAL D
[7]   Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET [J].
Antonini, A ;
Kazumata, K ;
Feigin, A ;
Mandel, F ;
Dhawan, V ;
Margouleff, C ;
Eidelberg, D .
MOVEMENT DISORDERS, 1998, 13 (02) :268-274
[8]   Parkinson disease neuropathology - Later-developing dementia and loss of the levodopa response [J].
Apaydin, H ;
Ahlskog, JE ;
Parisi, JE ;
Boeve, BF ;
Dickson, DW .
ARCHIVES OF NEUROLOGY, 2002, 59 (01) :102-112
[9]  
Ardouin C, 1999, ANN NEUROL, V46, P217, DOI 10.1002/1531-8249(199908)46:2<217::AID-ANA11>3.0.CO
[10]  
2-Z
12345678910